INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings, the monitoring agency for Indegene's Rs. 760 crore IPO (May 2024), has submitted its Q4FY26 report. The company has utilized Rs. 742.74 crore (97.7%) of IPO proceeds, with Rs. 17.26 crore remaining unutilized. The debt repayment to subsidiary ILSL Holdings (Rs. 395 crore) and issue expenses (Rs. 35.40 crore) are fully deployed. Capital expenditure deployment faced a 35-day delay for the first milestone and remains ongoing for the March 2026 milestone, with Rs. 6.72 crore still pending. A new object for Technology/Cybersecurity/Cloud infrastructure (Rs. 34.99 crore) was added via shareholder approval in August 2025, with Rs. 9.73 crore still to be deployed. The company has obtained special resolution approval for utilization variation.
The IPO proceeds are being deployed largely as planned with no material deviations. Minor delays in capital expenditure deployment and the reallocation of funds to technology initiatives are normal course adjustments post-IPO. The unutilized Rs. 17.26 crore is parked in fixed deposits earning 6.50% p.a., expected to be deployed by June 2026.